Mochida Pharmaceutical Co., Ltd. (TYO:4534)
3,665.00
+15.00 (0.41%)
Jan 21, 2026, 3:30 PM JST
Mochida Pharmaceutical Revenue
Mochida Pharmaceutical had revenue of 28.35B JPY in the quarter ending September 30, 2025, with 10.37% growth. This brings the company's revenue in the last twelve months to 109.05B, up 4.35% year-over-year. In the fiscal year ending March 31, 2025, Mochida Pharmaceutical had annual revenue of 105.16B with 2.21% growth.
Revenue (ttm)
109.05B
Revenue Growth
+4.35%
P/S Ratio
1.19
Revenue / Employee
72.31M
Employees
1,508
Market Cap
129.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 105.16B | 2.27B | 2.21% |
| Mar 31, 2024 | 102.89B | -376.00M | -0.36% |
| Mar 31, 2023 | 103.26B | -6.92B | -6.28% |
| Mar 31, 2022 | 110.18B | 7.18B | 6.98% |
| Mar 31, 2021 | 103.00B | 1.20B | 1.17% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |